PolyOne �Investor Presentation Slide Number 2 Slide Number 3 Slide Number 4 Slide Number 5 Slide Number 6 Slide Number 7 Slide Number 8 Slide Number 9 Slide Number 10 Slide Number 11 Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 Slide Number 23 Slide Number 24 Slide Number 25 Slide Number 26 Slide Number 27 Slide Number 28 Slide Number 29 Slide Number 30 Slide Number 31 Slide Number 32 Investor Presentation - March 2018 r4.pdf Investor Presentation - March 2018

Investor Presentation - November 2017 r4.pdf Investor Presentation - November 2017

August 13 - Key Bank 2013 Investor Presentation non-GAAP v2.pdf Reconciliation to Condensed Consolidated Balance Sheets

Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Avient Investor Presentation - Jefferies Industrials Conference August 2020.pdf August 2020 investor non-GAAP reconciliation.pdf August 2020 investor non-GAAP

Three Months Ended 2023年3月31日 Three Months Ended 2022年3月31日 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 20.8 $ 0.23 $ 64.4 $ 0.70 Special items, after tax 22.3 0.24 6.4 0.07 Amortization expense, after-tax 15.1 0.16 $ 10.8 $ 0.12 Adjusted net income / EPS $ 58.2 $ 0.63 $ 81.6 $ 0.89 March 31, Reconciliation of Pro Forma Sales 2023 2022 Sales $ 845.7 $ 892.2 APM pro forma adjustments — 94.9 Pro forma sales $ 845.7 $ 987.1 1 Three Months Ended Reconciliation to EBITDA and Adjusted EBITDA: 2023 2022 Net income from continuing operations – GAAP $ 21.3 $ 64.7 Income tax expense 7.7 20.0 Interest expense, net 28.8 16.9 Depreciation and amortization 50.5 37.6 EBITDA from continuing operations $ 108.3 $ 139.2 Special items, before tax 27.3 6.7 Depreciation and amortization included in special items (1.8) (2.1) Adjusted EBITDA $ 133.8 $ 143.8 Pro forma APM adjustments — 32.0 Pro forma adjusted EBITDA $ 133.8 $ 175.8 Pro forma adjusted EBITDA as a % of sales 15.8 % 17.8 % 2023 2022 Sales: Color, Additives and Inks $ 537.0 $ 649.5 Specialty Engineered Materials 309.7 243.1 Corporate (1.0) (0.4) Sales $ 845.7 $ 892.2 Operating income: Color, Additives and Inks $ 65.6 $ 94.5 Specialty Engineered Materials 43.1 38.3 Corporate (51.6) (30.6) Operating income $ 57.1 $ 102.2 Depreciation & amortization: Color, Additives and Inks $ 25.8 $ 26.0 Specialty Engineered Materials 21.2 7.8 Corporate 3.5 3.8 Depreciation & Amortization $ 50.5 $ 37.6 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 91.4 $ 120.5 Specialty Engineered Materials 64.3 46.1 Corporate (48.1) (26.8) Other income (expense), net 0.7 (0.6) EBITDA $ 108.3 $ 139.2 AVNT Q1 2023 Earnings Presentation v2 AVNT Q1 2023 Earnings Presentation 5.2 221pm IR Deck - AVNT-2023.03.31 (002).pdf

Three Months Ended Year Ended 2023 2022 2023 2022 Sales: Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0 Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4 Corporate (0.2) (1.2) (2.8) (2.5) Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Operating income: Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0 Specialty Engineered Materials 29.4 35.2 142.5 140.1 Corporate (48.1) (79.1) (205.6) (197.8) Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3 Other expense, net: $ 4.3 $ (28.4) $ 5.8 $ (59.7) Depreciation & amortization: Color, Additives and Inks $ 22.2 $ 25.2 $ 98.3 $ 101.3 Specialty Engineered Materials 19.8 20.3 81.5 48.7 Corporate 2.2 3.1 9.0 12.5 Depreciation & amortization $ 44.2 $ 48.6 $ 188.8 $ 162.5 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 84.0 $ 69.5 $ 358.2 $ 402.3 Specialty Engineered Materials 49.2 55.5 224.0 188.8 Corporate (45.9) (76.0) (196.6) (185.3) Other expense, net $ 4.3 $ (28.4) $ 5.8 $ (59.7) EBITDA $ 91.6 $ 20.6 $ 391.4 $ 346.1 Special items in EBITDA 22.3 86.8 110.4 162.5 EBITDA - excluding special items $ 113.9 $ 107.4 $ 501.8 $ 508.6 APM pro forma adjustments - 8 months 2022* — — — 83.1 Pro forma EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7 * Pro forma adjustment for January - August 2022 APM results (period before Avient ownership). 3 AVNT February IR Presentation.pdf Avient corporation�investor presentation DISCLAIMER Slide Number 3 Creating a world-class�sustainable organization Top-tier sustainability performance�and recognition Slide Number 6 Slide Number 7 Portfolio transformation Slide Number 9 END MARKET observations�(% of company sales) Regional observations�(% of company sales) Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 2023 segment, end market and Geography Color, Additives & Inks Specialty Engineered Materials Slide Number 26 AVNT Q4 2023 Earnings Presentation.pdf AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf IR Deck - AVNT-2023.12.31 (2.12.24 9PM Milestone February 12 0905 pm).pdf Attachment

Three Months Ended 2024年12月31日 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 48.3 $ 0.52 $ 27.8 $ 0.30 Special items, after-tax (18.0) (0.20) 5.4 0.06 Amortization expense, after-tax 14.8 0.17 15.0 0.16 Adjusted net income / EPS $ 45.1 $ 0.49 $ 48.2 $ 0.52 Year Ended 2024年12月31日 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 169.5 $ 1.84 $ 75.8 $ 0.83 Special items, after-tax 15.9 0.17 79.3 0.86 Amortization expense, after-tax 59.5 0.65 61.5 0.67 Adjusted net income / EPS $ 244.9 $ 2.66 $ 216.6 $ 2.36 Three Months Ended Year Ended Reconciliation to EBITDA and Adjusted EBITDA: 2024 2023 2024 2023 Net income from continuing operations – GAAP $ 48.5 $ 27.6 $ 170.7 $ 76.3 Income tax expense (benefit) 14.8 (7.0) 54.1 11.0 Interest expense 25.5 26.8 105.6 115.3 Depreciation and amortization from continuing operations 45.4 44.2 179.7 188.8 EBITDA from continuing operations $ 134.2 $ 91.6 $ 510.1 $ 391.4 Special items, before tax (23.9) 22.4 20.1 114.6 Interest expense included in special items — (0.1) (2.3) (2.3) Depreciation and amortization included in special items (0.3) — (1.5) (1.9) Adjusted EBITDA $ 110.0 $ 113.9 $ 526.4 $ 501.8 Adjusted EBITDA as a percent of sales 14.7 % 15.8 % 16.2 % 16.0 % 1 Three Months Ended Year Ended 2024 2023 2024 2023 Sales: Color, Additives and Inks $ 467.7 $ 459.4 $ 2,046.5 $ 2,007.4 Specialty Engineered Materials 279.7 259.8 1,196.8 1,138.2 Corporate (0.9) (0.2) (2.9) (2.8) Sales $ 746.5 $ 719.0 $ 3,240.4 $ 3,142.8 Gross margin: Color, Additives and Inks $ 152.6 $ 148.3 $ 681.1 $ 631.2 Specialty Engineered Materials 84.2 78.1 374.9 341.8 Corporate 22.7 (17.5) 0.7 (80.5) Gross margin $ 259.5 $ 208.9 $ 1,056.7 $ 892.5 Selling and administrative expense: Color, Additives and Inks $ 92.8 $ 86.5 $ 384.9 $ 371.3 Specialty Engineered Materials 49.6 48.7 207.7 199.3 Corporate 31.5 30.6 134.8 125.1 Selling and administrative expense $ 173.9 $ 165.8 $ 727.4 $ 695.7 Operating income: Color, Additives and Inks $ 59.8 $ 61.8 $ 296.2 $ 259.9 Specialty Engineered Materials 34.6 29.4 167.2 142.5 Corporate (8.8) (48.1) (134.1) (205.6) Operating income $ 85.6 $ 43.1 $ 329.3 $ 196.8 Depreciation and amortization: Color, Additives and Inks $ 21.9 $ 22.2 $ 87.5 $ 98.3 Specialty Engineered Materials 21.0 19.8 82.1 81.5 Corporate 2.5 2.2 10.1 9.0 Depreciation and amortization $ 45.4 $ 44.2 $ 179.7 $ 188.8 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 81.7 $ 84.0 $ 383.7 $ 358.2 Specialty Engineered Materials 55.6 49.2 249.3 224.0 Corporate (6.3) (45.9) (124.0) (196.6) Other income, net 3.2 4.3 1.1 5.8 EBITDA from continuing operations $ 134.2 $ 91.6 $ 510.1 $ 391.4 Special items, before tax (23.9) 22.4 20.1 114.6 Interest expense included in special items — (0.1) (2.3) (2.3) Depreciation and amortization included in special items (0.3) — (1.5) (1.9) Adjusted EBITDA $ 110.0 $ 113.9 $ 526.4 $ 501.8 2 Year Ended December 31, Adjusted Free Cash Flow Calculation 2024 2023 Cash provided by operating activities $ 256.8 $ 201.6 Taxes paid on gain on sale of business — 104.1 One-time payout associated with deferred compensation plans 20.8 — Adjusted cash provided by operating activities $ 277.6 $ 305.7 Capital expenditures (121.9) (119.4) Adjusted free cash flow $ 155.7 $ 186.3 Three Months Ended 2024年3月31日 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 49.4 $ 0.54 Special items, after-tax 5.5 0.06 Amortization expense, after-tax 14.9 0.16 Adjusted net income / EPS $ 69.8 $ 0.76 3 AVNT Q4 2024 webcast slides_w_non-GAAP.pdf AVNT Q4 2024 webcast slides_v16.pdf Webcast slides w EPS fix.pdf AVNT Q4 2024 webcast slides_w_non-GAAP IR Deck - AVNT-2024.12.31 2.06.25 12PM.pdf Attachment

Imerys, “Specialty Carbons for Polymer Compounds” http://www.imerys-graphite-and-carbon.com/wordpress/wp-app/uploads/2014/04/Polymer_compounds1.pdf 2http://cameo.mfa.org/wiki/Metallic_fiber

CAFE: Corporate Average Fuel Economy >50% Improvement REDUCE – TAKEAWAY Reducing Energy Consumption and Dependence on Fossil Fuels Drives Growth Projections Examples Covered 45% Other Applications 2022PF $310M 38 46 CAFE1 Miles Per Gallon Proposed Requirements HOW WE ENABLE SUSTAINABILITY Preserve Woon Keat Moh Senior Vice President, President of Color, Additives and Inks – Americas and Asia Avient Corporation 61 PRESERVE Avient Corporation 62 • Preserving Key Natural Resources - Companies are being challenged to mitigate high environmental impact processes such as water-intensive textile dyeing or food spoilage • Incorporating Renewable Materials - Adoption of bio-based raw materials requires design and formulation expertise to overcome performance shortcomings of neat resins • Increasing Healthcare Regulations - Utilizing sustainable materials in healthcare applications requires considerable support in navigating complex regulatory requirements • Increasing Regulatory Compliance - Non-Intentionally Added Substances (NIAS) need to be controlled in sensitive applications • Enabling Faster and More Reliable Connectivity – Substantial investments in 5G infrastructure are required to unlock the potential of the Internet of Things Solutions to preserve and protect natural resources & human life Avient Corporation 63 Spin Dyed Precolor Textile Yarn Renol™ Spin Dyeing Colorants • Replaces water-based dye processes to reduce waste creation • Conserves water and energy LESS WATER PROTECTIVE DENIM Dyneema® Workwear Solutions • Improves tear resistance 50-100% • More protective than competitive alternatives • Enables the amount of protective fiber to be reduced without sacrificing performance 600% IMPROVED ABRASION RESISTANCE Clothing & Textiles 2022 Revenue: $49M Avient Corporation 64 Low Cure Textile Inks Avient Specialty Inks™ Low Cure Inks • Decreases energy consumption • Reduces scrap due to heat-related defects SAVES ENERGY Clothing & Textiles 2022 Revenue: $40M BIO-BASED FORMULATIONS Water Based Textile Inks Zodiac™ Aquarius™ Specialty Inks • Incorporates bio-based materials • Non-formaldehyde solutions available • Reduces waste by enabling high open screen time Avient Corporation 65 Mosquito Netting Cesa™ Fiber Anti-Mosquito Additives • Helps control malaria • Protects consistently using a controlled release of insecticide • Expands access to healthcare breakthroughs to global communities ANNUAL NEW MALARIA CASES 200 Million Antimicrobial Protection Cesa™ WithStand™ Antimicrobial Additives • Reduces microbial / mold growth • Helps reduce odor, staining, discoloration • Excellent comfort and wearability • Chemical resistance - will not discolor or degrade REDUCES MICROBES 2022 Revenue: $5M Avient Corporation 66 Cut-Resistant Gloves Dyneema® Solutions • Incorporates bio-based materials • Reduces carbon emissions • Excellent wearability / comfort WORK INJURIES REDUCES Rescue Rope Dyneema® Solutions • Superior strength-to-weight ratio • High break load • Extraordinary reliability SAVES LIVES 2022 Revenue: $106M Body Armor Dyneema® Protective Solutions • Exceptional trauma protection • Excellent wearability LIGHTER THAN ARAMID FIBER 35% Avient Corporation 67 BIO-DERIVED Pharmaceutical Tubing Versaflex™ Healthcare Pharma Tubing Formulations NEU™ Specialty Engineered Materials • Facilitates incorporation of sustainable materials with healthcare device manufacturers • Eliminates vulcanization processes Medical 2022 Revenue: $40M NON-PHTHALATE Respiratory Conduit Versaflex™ Healthcare Corrugated Tubing Formulations • Non-Phthalate • ISO 10993 & USP Class VI compliant Avient Corporation 68 UP TO BIO-BASED CARRIER Medical Devices Mevopur™ Bio-Based Colorants • Minimizes risk through pre-testing • Provides vital regulatory compliance • Minimizes global supply chain risk with validated backup supply Continuous Glucose Monitoring and Auto Injectors Trilliant™ Healthcare Polymer Solutions • Impact performance • Chemical resistance ENABLES HOME CARE Medical 2022 Revenue: $16M Avient Corporation 69 Fiber Optic Cable and Jacketing Fiber-Line™ Optical Fiber Cable Components • Reduction in weight & energy usage • Thermal and abrasion resistant • Extends product life ENABLES CONNECTIVITY Cable Micromodules ECCOH™ Low Smoke Formulations • Non-halogen • Low smoke and toxicity SUPPORTS SUSTAINABLE INFRASTRUCTURE Base Station Components Edgetek™ Low-Density Formulations • Low density – lighter weight • Low warpage & thermal conductivity EXTENDS PRODUCT LIFE Antenna Components PREPERM™ Low Loss Dielectric Formulations • Replaces costly ceramics • Consistent and efficient antenna performance ENHANCES PERFORMANCE 5G Infrastructure 2022 Revenue: $39M Avient Corporation 70 “Nike has partnered with Avient extensively over the years because of their leadership in eco-friendly screen printing inks.”

Segment highlights COLOR, ADDITIVES & INKS Color, Additives & Inks Specialty Engineered Materials Specialty Engineered Materials Performance Products & Solutions Performance Products & Solutions DISTRIBUTION Target end markets & �application examples Slide Number 26 Slide Number 27 Slide Number 28 Slide Number 29 Slide Number 30 Slide Number 31 Slide Number 32 Slide Number 33 Slide Number 34 Slide Number 35 Slide Number 36 Slide Number 37 Investor Presentation - March 2018 r4.pdf Investor Presentation - March 2018